Distributor-as-Holder Risk: Avoiding Registration Hostage Situations in Mexico
Updated: 2026-11-11 · GRZAN Regulatory Team · Verification date 2026-10-20
1. Key takeaways
Allowing a commercial distributor to also act as the Mexican registration holder binds market access rights and the commercial relationship to the same entity. If the cooperation breaks down, the manufacturer’s ability to deal with its own registration depends on whether the distributor cooperates. The solution is to set the holder up as a compliance entity independent of the commercial channel, and to agree transfer terms in the contract. This is not an exotic risk: channel disputes are among the most common triggers of market-access crises in Mexico, and the cost of prevention at the drafting stage is small compared with the cost of negotiating a transfer from a weak position after the relationship has failed. The pattern repeats across product categories, which is why experienced manufacturers treat holder selection as a governance decision made before the first shipment, not as a clause to be fixed later.
- The entity named on the registration is the holder in law; if the distributor holds, the certificate sits in the distributor’s name.
- A change of holder name goes through a COFEPRIS procedure and is charged at 50% of the registration fee; without cooperation, timing and cost are outside the manufacturer’s control.
- One registration can list multiple importers, so the registration does not have to become part of the channel.
- Technical vigilance duties follow the holder: NOM-240-SSA1-2012 section 6.7.1 places the vigilance unit with the titular.
- Under NOM-137-SSA1-2025, the holder must be substantively involved in labelling and instructions for use; purely nominal holders are no longer sustainable.
2. Legal basis
The hostage risk is created by the interaction of three instruments: the vigilance standard that fixes duties on the holder, the regulation that defines the holder’s standing, and the Federal Rights Law that prices the way out. Understanding how they fit together explains why the risk is structural rather than behavioural, and why good contracts alone cannot fully neutralise it: they allocate leverage, but only structure changes who holds the certificate.
| NOM-240-SSA1-2012 | DOF 2012-10-30, section 6.7.1 | The technical vigilance unit obligation rests with the holder; distributors have only a secondary duty to report to the holder |
| Reglamento de Insumos para la Salud (RIS), amendment decree DOF 2026-04-24 | Article 180, item II | Where manufacturing is not by a parent company, a letter of authorisation from the manufacturer must be submitted |
| Ley Federal de Derechos | Article 195-A | A change of holder name is charged at 50% of the registration fee |
3. Expert insights
Insight one: the entity on the registration record is the holder in law. If the distributor holds the registration, the certificate is in the distributor’s name. The manufacturer’s contractual rights cannot be asserted directly against the registration record. In a dispute this asymmetry becomes the whole game: the manufacturer may be right commercially and still be unable to file, amend, renew or answer the authority, because every formal action runs through the titular of record.
Insight two: the transfer requires the other side’s cooperation. A change of holder name must go through a COFEPRIS procedure and is charged at 50% of the registration fee. If the other party does not cooperate, the manufacturer must find another route, and neither the time nor the cost is within its control. This is precisely the scenario the independent-holder structure is designed to prevent: the exit price of the relationship should never include the market access itself.
Insight three: one registration can carry multiple importers. The holder can add multiple importers under a single registration, so the registration itself does not need to become part of the channel. This provides a technical path for resolving channel conflicts: new distributors can be enabled through listing rather than through repeated changes to the registration, and the certificate stays with the entity the manufacturer chose.
Insight four: technical vigilance duties follow the holder. Section 6.7.1 of NOM-240-SSA1-2012 places the obligation to establish the technical vigilance unit on the holder. Where the distributor holds, the vigilance system is also built at the distributor, and the manufacturer’s grip on post-market data weakens. Complaints, incident reports and trend information all pass through an entity whose incentives in a dispute may not align with the manufacturer’s.
Insight five: the 2025 labelling standard requires substantive holder involvement. NOM-137-SSA1-2025 makes the holder share responsibility with the manufacturer for defining the intended use and participate in the review of the instructions for use. A purely nominal holder cannot sustain this role under the new standard, which raises the practical bar for who can serve as titular at all and further argues for a professional, independent holder.
4. Practical recommendations
- Prefer an independent third-party holder structure so that the registration and the channel are separated at the structural level, not merely at the contractual level.
- If the channel partner must hold, state the transfer trigger conditions, cooperation obligations, timelines and liquidated damages in the distribution agreement, so that non-cooperation carries a defined price.
- Use the mechanism of listing multiple importers on one registration to avoid repeated registration changes each time a new channel is added.
- Keep the technical vigilance system under the holder’s control while reserving the manufacturer’s rights of data access and of decision on reports, so post-market information remains visible to the party that owns the product.
- Ensure the holder substantively participates in the review of labelling and instructions for use, satisfying the requirements of NOM-137-SSA1-2025 rather than leaving the duty unperformed.
5. Verification checklist
- □ The holder is independent of the commercial channel
- □ The distribution agreement contains transfer trigger conditions and cooperation obligations
- □ The multiple-importers-per-registration mechanism has been used
- □ Rights over vigilance data and report decisions have been agreed
- □ The holder has substantively participated in the review of labelling and instructions for use
- □ Transfer fees are budgeted at the 50% tier
Regulatory information verified as of October 28, 2026.
How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the Mexican market. Our team manages COFEPRIS registrations and equivalence (equivalencia) reviews, coordinates third-party authorised centre routes, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com
Disclaimer
Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.
About GRZAN
GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.
GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.
Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.
What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.
Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.
Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.
Take your devices global with GRZAN
We work with manufacturers worldwide to open new markets with a clear regulatory pathway.
Contact us